Fabrice Beau

2.0k total citations
49 papers, 1.6k citations indexed

About

Fabrice Beau is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Fabrice Beau has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cancer Research, 27 papers in Oncology and 25 papers in Molecular Biology. Recurrent topics in Fabrice Beau's work include Protease and Inhibitor Mechanisms (28 papers), Peptidase Inhibition and Analysis (26 papers) and Chemical Synthesis and Analysis (7 papers). Fabrice Beau is often cited by papers focused on Protease and Inhibitor Mechanisms (28 papers), Peptidase Inhibition and Analysis (26 papers) and Chemical Synthesis and Analysis (7 papers). Fabrice Beau collaborates with scholars based in France, Greece and United States. Fabrice Beau's co-authors include Vincent Dive, Athanasios Yiotakis, Laurent Devel, Dimitris Georgiadis, Bertrand Czarny, Philippe Cuniasse, Magdalini Matziari, Anastasios Makaritis, E.A. Stura and Philippe Cuniasse and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Advanced Functional Materials.

In The Last Decade

Fabrice Beau

48 papers receiving 1.6k citations

Peers

Fabrice Beau

MB

ONCOL

CR

OC

HEMAT

Dimitris Georgiadis Greece

A.G. Pavlovsky United States

Michele McTigue United States

Gerard M. McGeehan United States

Frank Grams Germany

John E. Kerrigan United States

Eric B. Springman United States

Renae M. Crosby United States

Daniel P. Sutherlin United States

Rashid Syed United States

Dimitris Georgiadis Greece

Fabrice Beau

1.2k ×1.5

MB

893 ×1.2

ONCOL

370 ×0.6

CR

697 ×1.9

OC

154 ×1.1

HEMAT

Citations per year, relative to Fabrice Beau Fabrice Beau (= 1×) peers Dimitris Georgiadis

Countries citing papers authored by Fabrice Beau

Since Specialization

Citations

This map shows the geographic impact of Fabrice Beau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Beau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Beau more than expected).

Fields of papers citing papers by Fabrice Beau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Beau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Beau. The network helps show where Fabrice Beau may publish in the future.

Co-authorship network of co-authors of Fabrice Beau

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Beau. A scholar is included among the top collaborators of Fabrice Beau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Beau. Fabrice Beau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Koudelka, Tomas, Franka Scharfenberg, Dimitris Georgiadis, et al.. (2025). Targeted approach to determine the impact of cancer-associated protease variants. Science Advances. 11(7). eadp5958–eadp5958. 1 indexed citations

2.

Malgorn, Carole, Dominique Georgin, Fabrice Beau, et al.. (2023). Correlative radioimaging and mass spectrometry imaging: a powerful combination to study¹⁴C-graphene oxidein vivobiodistribution. Nanoscale. 15(11). 5510–5518. 5 indexed citations

3.

Malgorn, Carole, François Bécher, Carole Fruchart‐Gaillard, et al.. (2023). A New Affinity-Based Probe to Profile MMP Active Forms. Methods in molecular biology. 2747. 29–39.

4.

Kamińska, M., Carole Malgorn, Carole Fruchart‐Gaillard, et al.. (2021). Ligand‐Directed Modification of Active Matrix Metalloproteases: Activity‐based Probes with no Photolabile Group. Angewandte Chemie International Edition. 60(33). 18272–18279. 14 indexed citations

5.

Kamińska, M., Carole Malgorn, Carole Fruchart‐Gaillard, et al.. (2021). Ligand‐Directed Modification of Active Matrix Metalloproteases: Activity‐based Probes with no Photolabile Group. Angewandte Chemie. 133(33). 18420–18427. 1 indexed citations

6.

Servent, Denis, Carole Malgorn, Sophie Gil, et al.. (2021). First evidence that emerging pinnatoxin-G, a contaminant of shellfish, reaches the brain and crosses the placental barrier. The Science of The Total Environment. 790. 148125–148125. 7 indexed citations

7.

Devel, Laurent, Gunter Almer, Claudia Cabella, et al.. (2019). Biodistribution of Nanostructured Lipid Carriers in Mice Atherosclerotic Model. Molecules. 24(19). 3499–3499. 13 indexed citations

8.

Toczek, Jakub, Kiran Gona, Hye-Yeong Kim, et al.. (2019). Novel Matrix Metalloproteinase 12 Selective Radiotracers for Vascular Molecular Imaging. Journal of Medicinal Chemistry. 62(21). 9743–9752. 13 indexed citations

9.

Razavian, Mahmoud, Dimitris Georgiadis, Fabrice Beau, et al.. (2016). Optical imaging of MMP-12 active form in inflammation and aneurysm. Scientific Reports. 6(1). 38345–38345. 22 indexed citations

10.

Vera, Laura, et al.. (2014). Halogen Bonding Controls Selectivity of FRET Substrate Probes for MMP-9. Chemistry & Biology. 21(3). 408–413. 25 indexed citations

11.

Stura, E.A., Sarah Bregant, Fabrice Beau, et al.. (2012). Structural Framework for Covalent Inhibition of Clostridium botulinum Neurotoxin A by Targeting Cys165. Journal of Biological Chemistry. 287(40). 33607–33614. 17 indexed citations

12.

Devel, Laurent, Fabrice Beau, Laura Vera, et al.. (2012). Simple Pseudo-dipeptides with a P2′ Glutamate. Journal of Biological Chemistry. 287(32). 26647–26656. 31 indexed citations

13.

Devel, Laurent, Bertrand Czarny, Fabrice Beau, et al.. (2010). Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1′ cavity. Biochimie. 92(11). 1501–1508. 75 indexed citations

14.

Dabert-Gay, Anne-Sophie, Bertrand Czarny, Laurent Devel, et al.. (2008). Molecular Determinants of Matrix Metalloproteinase-12 Covalent Modification by a Photoaffinity Probe. Journal of Biological Chemistry. 283(45). 31058–31067. 27 indexed citations

15.

Steer, David L., Sarah Bregant, Laurent Devel, et al.. (2007). Cross‐Linking Yield Variation of a Potent Matrix Metalloproteinase Photoaffinity Probe and Consequences for Functional Proteomics. Angewandte Chemie International Edition. 46(18). 3275–3277. 38 indexed citations

16.

Cuniasse, Philippe, Laurent Devel, Anastasios Makaritis, et al.. (2004). Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs. Biochimie. 87(3-4). 393–402. 103 indexed citations

17.

Dive, Vincent, Kumari L. Andarawewa, Anne Boulay, et al.. (2004). Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases. International Journal of Cancer. 113(5). 775–781. 26 indexed citations

18.

Dive, Vincent, Dimitris Georgiadis, Magdalini Matziari, et al.. (2004). Phosphinic peptides as zinc metalloproteinase inhibitors. Cellular and Molecular Life Sciences. 61(16). 2010–9. 78 indexed citations

19.

Georgiadis, Dimitris, Fabrice Beau, Bertrand Czarny, et al.. (2003). Roles of the Two Active Sites of Somatic Angiotensin-Converting Enzyme in the Cleavage of Angiotensin I and Bradykinin. Circulation Research. 93(2). 148–154. 132 indexed citations

20.

Mucha, Artur, Philippe Cuniasse, Rama Kannan, et al.. (1998). Membrane Type-1 Matrix Metalloprotease and Stromelysin-3 Cleave More Efficiently Synthetic Substrates Containing Unusual Amino Acids in Their P1′ Positions. Journal of Biological Chemistry. 273(5). 2763–2768. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact